An Efficacy and Safety Study of Sodium Oligo-mannurarate (GV-971) Capsule for the Treatment of Alzheimer's Disease

NCT02293915 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

818

Enrollment

INDUSTRY

Sponsor class

Conditions

Mild to Moderate Alzheimer Disease
Cognitive Impairment

Interventions

DRUG: Sodium oligo-mannurarate 900mg
DRUG: Placebo

Sponsor

Shanghai Greenvalley Pharmaceutical Co., Ltd.